UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
AMSTERDAM, THE NETHERLANDS -- (Marketwire) -- 09/10/10 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, today announced...
PHILADELPHIA, PA -- (Marketwire) -- 09/02/10 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, is scheduled to participate...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...
As filed with the Securities and Exchange Commission on August 6, 2010. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE...
AMSTERDAM, THE NETHERLANDS -- (Marketwire) -- 08/06/10 -- Eurand N.V. (NASDAQ: EURX) Recent Highlights: -- Second quarter revenues grew 8% to...
PHILADELPHIA, PA -- (Marketwire) -- 07/29/10 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that John...
AMSTERDAM, THE NETHERLANDS -- (Marketwire) -- 07/19/10 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, will host a...
YARDLEY, PA -- (Marketwire) -- 06/17/10 -- Eurand Pharmaceuticals, Inc., a subsidiary of global specialty pharmaceutical company Eurand N.V...
AMSTERDAM, THE NETHERLANDS -- (Marketwire) -- 06/16/10 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, today announced...
NEW YORK, May 14, 2010 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced today the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.